Press Releases

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.

CIRCOR’s Highlights BB PEP Series Pumps for Polymer Extrusion

CIRCOR International, Inc., a leading manufacturer and marketer of differentiated technology products and sub-systems, highlights its new BB PEP Series pumps, engineered for high-precision performance in polymer extrusion applications. With a focus on consistent, accurate performance, the BB PEP Series addresses critical demands such as uniformity, durability, and ease of maintenance in the chemical, industrial and life sciences industries.

eClinical Solutions Positioned as Highest Leader in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights

Beta Bionics Secures $60 Million in Series E Funding to Advance Diabetes Care Innovations

In November 2024, a $60 million fundraising transaction for Series E preferred stock was successfully closed by Beta Bionics, Inc., a trailblazing leader in the creation of cutting-edge diabetes treatment solutions.

Creative Biolabs Vaccine Solutions: Jumping into Action to Take on Monkeypox

With the global fight against the monkeypox epidemic intensifying, Creative Biolabs has risen to the occasion by introducing a comprehensive monkeypox virus vaccine development strategy.

Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management

Augurex Life Sciences and Quest Diagnostics have partnered to reintroduce a lab-developed test based on the 14-3-3η (eta) biomarker for rheumatoid arthritis (RA) diagnosis and management in the U.S. Quest will offer the test starting December 2, 2024, through its San Juan Capistrano laboratory, with blood samples collected at over 2,000 patient service centers nationwide. The 14-3-3eta test helps identify RA-specific protein levels, aiding in earlier treatment decisions and improved care for patients with inflammatory diseases.

Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens

Illumina Rolls out MiSeq i100 Series to Reshape Next-Generation Sequencing

The MiSeq i100 Series of sequencing equipment was introduced by Illumina, a multinational corporation dedicated to DNA sequencing and array-based technologies. The new systems are designed to improve next-generation sequencing (NGS) capabilities for labs by providing quick turnaround and user-friendliness.

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

PathAI, a global leader in AI-powered digital pathology solutions and the developer of the market-leading AISight1 Image Management System (IMS), today announced the integration of several AI products from market leading digital pathology companies, including Deep Bio, DoMore Diagnostics, Paige, and Visiopharm. Through these collaborations, PathAI will provide algorithms from these developers directly within its AISight IMS, reinforcing its commitment to offering the most versatile, reliable, and interoperable IMS on the market.

Sakura Finetek Europe and MEDIPATH announced their collaboration to improve patient journey for cancer screenings and diagnoses

Sakura Finetek Europe and MEDIPATH announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management.

Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients

Owkin’s MSIntuit® CRC v2, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of Proscia’s precision medicine AI portfolio.

City Therapeutics Debuts with $135M Series A to Revolutionize RNAi-Based Therapeutics

City Therapeutics, which uses next-generation engineering of small interfering RNAs (siRNAs) to drive improvements in RNA interference (RNAi)--based therapeutics, has announced its debut along with a $135 million Series A funding.

Coronado Research Limited announce the appointment of Alexander McCormick as Chief Commercial Officer

Coronado Research announced today that Alexander McCormick has been appointed as Chief Commercial Officer.

Augurex and New Day Diagnostics Announce Launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents; Enabling a First-In-Class Diagnostic Test for Axial Spondyloarthritis

• Augurex launches Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs), supporting the development of a first-in-class diagnostic test for axial spondyloarthritis (axSpA) by New Day Diagnostics. • The new laboratory developed test, which uses Anti-14-3-3eta Multiplex ASRs as components, aims to reduce the extensive diagnostic delay typically experienced by axSpA patients, provide clinicians with a reliable tool to help improve patient outcomes, and potentially aid the early diagnosis and treatment of axSpA.

Association for Molecular Pathology Publishes Joint Consensus Report on SARS-CoV-2 Genomic Surveillance for Clinical Hospitals and Public Health Laboratories

AMP announced a joint consensus report with APHL that describes best practices and offers key pre-analytical, analytical, and post-analytical considerations to help improve critical NGS-based surveillance programs.

Gifthealth Announces Strategic Partnership with United Digestive

Partnership expands Gifthealth’s presence to cover 25% of gastroenterologists nationally.

Oxford Nanopore and Wasatch BioLabs Announce Collaboration to Transform DNA Methylation Analysis with New dWMS Product

The collaborative development between Oxford Nanopore and Wasatch BioLabs marks an exciting milestone in the field of epigenetics and signals a commitment to empowering researchers with innovative, reliable tools. As the product nears its anticipated market release, the scientific community awaits a new era of discovery and understanding in methylation research, fueled by real-time, comprehensive insights into the methylome.

William H Morris, MD MBA, Joins Ambience Healthcare as Chief Medical Officer

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

MMS has announced that its regulatory team has been selected as one of three top finalists in the Fierce CRO Awards for Leadership in Regulatory Compliance.

Octalsoft Honored with Times Gujarat Icon 2024 Award for Excellence in Technology and Innovation

Octalsoft, a global leader in clinical trial and healthcare technology solutions, is proud to announce its recognition as a Times Gujarat Icon 2024 Award winner, acknowledging the company’s exceptional contributions to the technology and healthcare sectors.